Work

A phase 1 study of ABT-806 in subjects with advanced solid tumors

Year: 2015

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-015-0234-6

Authors: James M. Cleary, David A. Reardon, Nilofer Azad, Leena Gandhi, Geoffrey I. Shapiro, Jorge Chaves, Michelle Pedersen, Peter Ansell, William Ames, Hao Xiong, Wijith Munasinghe, Matt Dudley, Edward B. Reilly, Kyle Holen, Rod Humerickhouse

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Johns Hopkins University, Sidney Kimmel Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Northwest Medical Specialties, AbbVie (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1982244230

FWCI: 2.34

Cites: 33

Cited by: 40

Related to: 10